NAV — Navco Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Navco Pharmaceuticals, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.

	2022 June 30th	2023 September 30th	2024 September 30th
Period Length:	—	—	—
Source:	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS
Status:	Final	Final	Final
Cash
Cash and Short Term Investments	0.002	0.235	0.007
Net Total Accounts Receivable
Net Total Receivables	0.11	0.046	0.066
Total Inventory
Prepaid Expenses
Total Current Assets	0.112	0.711	0.074
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	0.184	0.001
Net Intangible Assets
Total Assets	0.112	0.932	0.075
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.109	0.753	0.932
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	0.109	0.844	0.932
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	0.003	0.087	-0.857
Total Liabilities & Shareholders' Equity	0.112	0.932	0.075
Total Common Shares Outstanding